Traws Pharma Inc. Common Stock (TRAW)
Stock · NASDAQ · Health Care
$0.59as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$0.535625
Industry
Biotechnology: Pharmaceutical Preparations
Fundamentals
- Market cap
- $8.21M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- —
- Avg. volume
- —
How Traws Pharma Inc. Common Stock Makes Money
Where the revenue actually goes — FY2024 annual results
Source: 10-K filed Mar 31, 2025 · via SEC EDGAR / Finnhub
Traws Pharma Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- TRAWTraws Pharma Inc. Common Stock$0.59▲ 0.00%Market cap $8.21MP/E —
- SNGXSoligenix Inc. Common Stock$0.38▲ 0.00%Market cap $8.24MP/E —$0.28$3.22
- APREAprea Therapeutics Inc. Common stock$0.8387▼ 2.48%Market cap $7.83MP/E —$0.548$1.69
- XCURExicure Inc. Common Stock$1.34▼ 5.32%Market cap $8.60MP/E —$1.05$9.48
- PCSAProcessa Pharmaceuticals Inc. Common Stock$2.07▼ 1.90%Market cap $7.65MP/E 3.31$1.67$14.24
- CNSPCNS Pharmaceuticals Inc. Common Stock$5.52▲ 0.11%Market cap $7.65MP/E —$1.9$10.59
- LEXXLexaria Bioscience Corp. Common Stock$10.35▼ 11.39%Market cap $8.82MP/E —$4.21$23.25
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| TRAW Traws Pharma Inc. Common Stock | $8.21M | — | $0.59 | ▲ 0.00% | |
| SNGX Soligenix Inc. Common Stock | $8.24M | — | $0.38 | ▲ 0.00% | $0.28$3.22 |
| APRE Aprea Therapeutics Inc. Common stock | $7.83M | — | $0.8387 | ▼ 2.48% | $0.548$1.69 |
| XCUR Exicure Inc. Common Stock | $8.60M | — | $1.34 | ▼ 5.32% | $1.05$9.48 |
| PCSA Processa Pharmaceuticals Inc. Common Stock | $7.65M | 3.31 | $2.07 | ▼ 1.90% | $1.67$14.24 |
| CNSP CNS Pharmaceuticals Inc. Common Stock | $7.65M | — | $5.52 | ▲ 0.11% | $1.9$10.59 |
| LEXX Lexaria Bioscience Corp. Common Stock | $8.82M | — | $10.35 | ▼ 11.39% | $4.21$23.25 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- HC Wainwright & Co. Reiterates Neutral on Traws Pharma, Maintains $1 Price TargetBenzinga · 8/18/2026
- Traws Pharma Q2 EPS $(0.16) Beats $(0.34) EstimateBenzinga · 8/14/2026
Insider Activity
Insider Actions →Acquired
3.43M
Disposed
0
- Pauza Charles David · July 9, 2026 · Grant97.0K
- Savchuk Nikolay · July 9, 2026 · Grant93.0K
- CAUTREELS WERNER · July 9, 2026 · Grant14.2K
- Parker Charles Nolan · July 9, 2026 · Grant90.0K
- Redfield Robert · July 9, 2026 · Grant84.0K
- Clarke Trafford · July 9, 2026 · Grant14.2K
- Shoemaker Mary Teresa · July 9, 2026 · Grant14.2K
- Dukes Iain D. · July 9, 2026 · Grant274.0K
- Leaman John Harold · July 9, 2026 · Grant14.2K
- STOVER JACK E · July 9, 2026 · Grant14.2K
- ORBIMED ADVISORS LLC · April 16, 2026 · Buy1.79M
- ORBIMED ADVISORS LLC · April 16, 2026 · Buy597.7K @ $1.67
- Parker Charles Nolan · March 8, 2026 · Grant104.5K
- Redfield Robert · March 8, 2026 · Grant108.9K
- Pauza Charles David · March 8, 2026 · Grant118.4K
Institutional Ownership
March 31, 2026
- Total shares held
- 3.59M
- Total value held
- $6.57M
- Institutional holders
- 25
Top holders this quarter
- Unknown730.0K
- Unknown678.1K
- Unknown605.5K
- Unknown511.7K
- Unknown417.0K
- Unknown194.5K
- Unknown154.1K
- Unknown77.1K
- Unknown61.2K
- Unknown55.2K
See the full, filterable feed with live charts on the MarketWall dashboard.